Physical Activity a Vital Sign? 40 Steps to Safety Test for Patients With COVID-19

NCT ID: NCT04618835

Last Updated: 2021-02-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-01-11

Study Completion Date

2021-11-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Exertional desaturation is a feature of COVID-19. The study will measure vital signs of patients discharge by practitioners in primary care, secondary care or by paramedic practitioners. Patients will then undertake a 40-steps on the spot walk followed by measurements of heart rate and oxygen saturations for up to two minutes. Association of desaturation with 30 days hospital admission and mortality will be reported.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Covid19 Medical Emergencies

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Emergency presentations

Patients discharged after a presentation to practitioners in the community, primary and secondary care.

40-Steps-test

Intervention Type DIAGNOSTIC_TEST

40 steps performed on the spot

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

40-Steps-test

40 steps performed on the spot

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients are being considered for discharge to independent care
* Participant is willing and able to give informed consent for participation in the study.
* Patient with independent, stable, gait
* Patient is alert, attentive, coherent, and calm
* Male or Female, aged 18 years or above.

Exclusion Criteria

* Minor injuries
* Elective surgery patients
* Post-operative patients at discharge
* Requires supplemental oxygen
* Shortness of breath at rest (i.e. Borg or Numerical Rating Scale \>=2)
* Unstable angina
* Patients on long-term-oxygen therapy
* Pregnancy as stated by patient
* Oxygen saturations \< 95% on room air
* Resting heart rate \> 100 bpm
* Resting respiratory rate \> 25 bpm
* ECG with signs of acute ischemia in patients where an ECG has been requested by the treating clinician
* National Early Warning Score of 5 or more
* Nursing home residents, or those being transferred to a nursing home or similar care facility
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Oxford Brookes University

OTHER

Sponsor Role collaborator

Betsi Cadwaladr University Health Board

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr Christian P Subbe

Consultant Physician

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ysbyty Gwynedd

Menai Bridge, Gwynedd, United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Christian Subbe, DM

Role: CONTACT

+447771922890

Laura Langshaw

Role: CONTACT

+441248384384

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Christian Subbe

Role: primary

07771922890

Laura Langshaw

Role: backup

+441248384384

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

283998

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Burden of COVID-19 Survivorship
NCT04913129 COMPLETED NA